BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25363319)

  • 1. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.
    Torok S; Vegvari A; Rezeli M; Fehniger TE; Tovari J; Paku S; Laszlo V; Hegedus B; Rozsas A; Dome B; Marko-Varga G
    Br J Pharmacol; 2015 Feb; 172(4):1148-63. PubMed ID: 25363319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging.
    Connell JJ; Sugihara Y; Török S; Döme B; Tóvári J; Fehniger TE; Marko-Varga G; Végvári Á
    Anal Bioanal Chem; 2015 Mar; 407(8):2245-53. PubMed ID: 25424181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.
    Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT
    Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of sunitinib in gastrointestinal cancers other than GIST.
    Grávalos C; Grande E; Gasent JM
    Crit Rev Oncol Hematol; 2010 Oct; 76(1):36-43. PubMed ID: 20133148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
    Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
    Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.
    George S; Blay JY; Casali PG; Le Cesne A; Stephenson P; Deprimo SE; Harmon CS; Law CN; Morgan JA; Ray-Coquard I; Tassell V; Cohen DP; Demetri GD
    Eur J Cancer; 2009 Jul; 45(11):1959-68. PubMed ID: 19282169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice.
    Chew CC; Ng S; Chee YL; Koo TW; Liew MH; Chee EL; Modamio P; Fernández C; Mariño EL; Segarra I
    Invest New Drugs; 2017 Aug; 35(4):399-411. PubMed ID: 28285369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in mice.
    Liew MH; Ng S; Chew CC; Koo TW; Chee YL; Chee EL; Modamio P; Fernández C; Mariño EL; Segarra I
    Invest New Drugs; 2017 Apr; 35(2):145-157. PubMed ID: 28070719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib malate for the treatment of renal cell carcinoma.
    Wood L
    Expert Opin Pharmacother; 2012 Jun; 13(9):1323-36. PubMed ID: 22607009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.
    Fountzilas G; Fragkoulidi A; Kalogera-Fountzila A; Nikolaidou M; Bobos M; Calderaro J; Andreiuolo F; Marselos M
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):649-60. PubMed ID: 19655144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib.
    Fiorio Pla A; Brossa A; Bernardini M; Genova T; Grolez G; Villers A; Leroy X; Prevarskaya N; Gkika D; Bussolati B
    BMC Cancer; 2014 Dec; 14():939. PubMed ID: 25494980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor.
    Roskoski R
    Biochem Biophys Res Commun; 2007 May; 356(2):323-8. PubMed ID: 17367763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors.
    Torok S; Rezeli M; Kelemen O; Vegvari A; Watanabe K; Sugihara Y; Tisza A; Marton T; Kovacs I; Tovari J; Laszlo V; Helbich TH; Hegedus B; Klikovits T; Hoda MA; Klepetko W; Paku S; Marko-Varga G; Dome B
    Theranostics; 2017; 7(2):400-412. PubMed ID: 28042343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunitinib suppresses tumor growth and metastases in a highly metastatic mouse mammary cancer model.
    Tanaka Y; Shibata MA; Morimoto J; Otsuki Y
    Anticancer Res; 2011 Apr; 31(4):1225-34. PubMed ID: 21508369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
    Suddek GM
    Cancer Chemother Pharmacol; 2011 May; 67(5):1035-44. PubMed ID: 20652569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits from pharmacological and pharmacokinetic properties of sunitinib for clinical development.
    Sablin MP; Dreyer C; Colichi C; Bouattour M; Delbaldo C; Faivre S; Raymond E
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):1005-15. PubMed ID: 20636223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
    Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently.
    Lau CL; Chan ST; Selvaratanam M; Khoo HW; Lim AY; Modamio P; Mariño EL; Segarra I
    Fundam Clin Pharmacol; 2015 Aug; 29(4):404-16. PubMed ID: 26011058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.
    Liu J; Deng GH; Zhang J; Wang Y; Xia XY; Luo XM; Deng YT; He SS; Mao YY; Peng XC; Wei YQ; Jiang Y
    Psychoneuroendocrinology; 2015 Feb; 52():130-42. PubMed ID: 25437118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.